These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3718807)

  • 1. Stereoselective disposition of mexiletine in man.
    Grech-Belanger O; Turgeon J; Gilbert M
    Br J Clin Pharmacol; 1986 May; 21(5):481-7. PubMed ID: 3718807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of the enantiomers of mexiletine in humans.
    Igwemezie L; Kerr CR; McErlane KM
    Xenobiotica; 1989 Jun; 19(6):677-82. PubMed ID: 2763576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.
    Kwok DW; Kerr CR; McErlane KM
    Xenobiotica; 1995 Nov; 25(10):1127-42. PubMed ID: 8578769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rifampicin treatment on the kinetics of mexiletine.
    Pentikäinen PJ; Koivula IH; Hiltunen HA
    Eur J Clin Pharmacol; 1982; 23(3):261-6. PubMed ID: 6129140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective analysis of the enantiomers of mexiletine by high-performance liquid chromatography using fluorescence detection and study of their stereoselective disposition in man.
    McErlane KM; Igwemezie L; Kerr CR
    J Chromatogr; 1987 Apr; 415(2):335-46. PubMed ID: 3584372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of oral mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    Eur J Clin Pharmacol; 1983; 25(6):773-7. PubMed ID: 6662176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of mexiletine in renal insufficiency.
    Baudinet G; Henrard L; Quinaux N; El Allaf D; de Landsheere C; Carlier J; Dresse A
    Acta Cardiol Suppl; 1980; (25):55-65. PubMed ID: 6966453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced metabolism of mexiletine after phenytoin administration.
    Begg EJ; Chinwah PM; Webb C; Day RO; Wade DN
    Br J Clin Pharmacol; 1982 Aug; 14(2):219-23. PubMed ID: 7104173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine disposition: individual variation in response to urine acidification and alkalinisation.
    Mitchell BG; Clements JA; Pottage A; Prescott LF
    Br J Clin Pharmacol; 1983 Sep; 16(3):281-4. PubMed ID: 6626420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and bioavailability of mexiletine in healthy subjects.
    Häselbarth V; Doevendans JE; Wolf M
    Clin Pharmacol Ther; 1981 Jun; 29(6):729-36. PubMed ID: 7226704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of mexiletine enantiomers in rats.
    Igwemezie L; Beatch GN; Walker MJ; McErlane KM
    Xenobiotica; 1991 Sep; 21(9):1153-8. PubMed ID: 1788983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mexiletine kinetics in healthy subjects taking cimetidine.
    Klein A; Sami M; Selinger K
    Clin Pharmacol Ther; 1985 Jun; 37(6):669-73. PubMed ID: 4006366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective serum protein binding of mexiletine enantiomers in man.
    McErlane KM; Igwemezie L; Kerr CR
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):141-4. PubMed ID: 3589151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of flurbiprofen in man: influence of stereochemistry and age.
    Patel BK; Jackson SH; Swift CG; Hutt AJ
    Xenobiotica; 2003 Oct; 33(10):1043-57. PubMed ID: 14555340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mexiletine in renal insufficiency.
    El Allaf D; Henrard L; Crochelet L; Delapierre D; Carlier J; Dresse A
    Br J Clin Pharmacol; 1982 Sep; 14(3):431-5. PubMed ID: 7126416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cigarette smoking on mexiletine kinetics.
    Grech-Bélanger O; Gilbert M; Turgeon J; LeBlanc PP
    Clin Pharmacol Ther; 1985 Jun; 37(6):638-43. PubMed ID: 4006363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenous mexiletine in patients with acute myocardial infarction.
    Pentikäinen PJ; Halinen MO; Helin MJ
    J Cardiovasc Pharmacol; 1984; 6(1):1-6. PubMed ID: 6199590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ciprofloxacin on the stereoselective disposition of mexiletine in man.
    Labbé L; Robitaille NM; Lefez C; Potvin D; Gilbert M; O'Hara G; Turgeon J
    Ther Drug Monit; 2004 Oct; 26(5):492-8. PubMed ID: 15385831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cirrhosis of the liver markedly impairs the elimination of mexiletine.
    Pentikäinen PJ; Hietakorpi S; Halinen MO; Lampinen LM
    Eur J Clin Pharmacol; 1986; 30(1):83-8. PubMed ID: 3709636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans.
    Abolfathi Z; Fiset C; Gilbert M; Moerike K; Bélanger PM; Turgeon J
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1196-201. PubMed ID: 8371133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.